186 related articles for article (PubMed ID: 36065481)
1.
Tzortzakakis A; Papathomas T; Gustafsson O; Gabrielson S; Trpkov K; Ekström-Ehn L; Arvanitis A; Holstensson M; Karlsson M; Kokaraki G; Axelsson R
Scand J Urol; 2022; 56(5-6):375-382. PubMed ID: 36065481
[TBL] [Abstract][Full Text] [Related]
2. Clinical Performance of Technetium-99m-Sestamibi SPECT/CT Imaging in Differentiating Oncocytic Tumors From Renal Cell Carcinoma in Routine Clinical Practice.
Schober JP; Braun A; Ginsburg KB; Bell S; Castro Bigalli AA; Chen M; Wang R; Magee D; Bukavina L; Handorf E; Yu JQ; Chen DYT; Greenberg RE; Smaldone MC; Viterbo R; Correa AF; Uzzo RG; Kutikov A
J Urol; 2023 Sep; 210(3):438-445. PubMed ID: 37378576
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Accuracy of
Parihar AS; Mhlanga J; Ronstrom C; Schmidt LR; Figenshau RS; Dehdashti F; Wahl RL
J Nucl Med; 2023 Jan; 64(1):90-95. PubMed ID: 35772963
[TBL] [Abstract][Full Text] [Related]
4. Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.
Gorin MA; Rowe SP; Baras AS; Solnes LB; Ball MW; Pierorazio PM; Pavlovich CP; Epstein JI; Javadi MS; Allaf ME
Eur Urol; 2016 Mar; 69(3):413-6. PubMed ID: 26386607
[TBL] [Abstract][Full Text] [Related]
5. The Role of
Basile G; Fallara G; Verri P; Uleri A; Chiti A; Gianolli L; Pepe G; Tedde A; Algaba F; Territo A; Sanguedolce F; Larcher A; Gallioli A; Palou J; Montorsi F; Capitanio U; Breda A
Eur Urol; 2024 Jan; 85(1):63-71. PubMed ID: 37673752
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99 m-sestamibi single-photon emission computerised tomography (CT)/CT in the prediction of malignant versus benign small renal masses.
Viswambaram P; Swarbrick N; Picardo A; Hohnen A; Pham K; Macdonald W; Hayne D; Hamid A
BJU Int; 2022 Nov; 130 Suppl 3():23-31. PubMed ID: 35365966
[TBL] [Abstract][Full Text] [Related]
7. In Situ Metabolomics Expands the Spectrum of Renal Tumours Positive on
Papathomas T; Tzortzakakis A; Sun N; Erlmeier F; Feuchtinger A; Trpkov K; Bazarova A; Arvanitis A; Wang W; Bozoky B; Kokaraki G; Axelsson R; Walch A
Eur Urol Open Sci; 2020 Dec; 22():88-96. PubMed ID: 34337482
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness Analysis of
Su ZT; Patel HD; Huang MM; Meyer AR; Pavlovich CP; Pierorazio PM; Javadi MS; Allaf ME; Rowe SP; Gorin MA
Eur Urol Focus; 2021 Jul; 7(4):827-834. PubMed ID: 32115400
[TBL] [Abstract][Full Text] [Related]
9. Use of quantitative SPECT/CT reconstruction in
Jones KM; Solnes LB; Rowe SP; Gorin MA; Sheikhbahaei S; Fung G; Frey EC; Allaf ME; Du Y; Javadi MS
Ann Nucl Med; 2018 Feb; 32(2):87-93. PubMed ID: 29214562
[TBL] [Abstract][Full Text] [Related]
10. Characterizing Indeterminate Renal Masses with Molecular Imaging: the Role of
Reynolds AM; Porter KK
Curr Urol Rep; 2017 Sep; 18(11):86. PubMed ID: 28900880
[TBL] [Abstract][Full Text] [Related]
11. Protocol for a MULTI-centre feasibility study to assess the use of
Warren H; Wagner T; Gorin MA; Rowe S; Holman BF; Pencharz D; El-Sheikh S; Barod R; Patki P; Mumtaz F; Bex A; Kasivisvanathan V; Moore CM; Campain N; Cartledge J; Scarsbrook A; Hassan F; O'Brien TS; Stewart GD; Mendichovszky I; Dizdarevic S; Alanbuki A; Wildgoose WH; Wah T; Vindrola-Padros C; Pizzo E; Dehbi HM; Lorgelly P; Gurusamy K; Emberton M; Tran MGB
BMJ Open; 2023 Jan; 13(1):e067496. PubMed ID: 36693694
[TBL] [Abstract][Full Text] [Related]
12. Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses.
Sheikhbahaei S; Jones CS; Porter KK; Rowe SP; Gorin MA; Baras AS; Pierorazio PM; Ball MW; Higuchi T; Johnson PT; Solnes LB; Epstein JI; Allaf ME; Javadi MS
Clin Nucl Med; 2017 Apr; 42(4):e188-e193. PubMed ID: 28114223
[TBL] [Abstract][Full Text] [Related]
13. Use of
Almassi N; Gorin MA; Purysko AS; Rowe SP; Kaouk J; Allaf ME; Campbell SC; Rhee A
Urology; 2018 Mar; 113():206-208. PubMed ID: 29174943
[TBL] [Abstract][Full Text] [Related]
14. Machine Learning Integrating
Klontzas ME; Koltsakis E; Kalarakis G; Trpkov K; Papathomas T; Karantanas AH; Tzortzakakis A
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509214
[TBL] [Abstract][Full Text] [Related]
15. 99m Tc-MIBI SPECT/CT in a Case of Renal Oncocytosis.
Zhao Q; Dong A; Zuo C; Yang B
Clin Nucl Med; 2023 Sep; 48(9):830-832. PubMed ID: 37486723
[TBL] [Abstract][Full Text] [Related]
16. The role of Tc-99m MIBI scintigraphy in clinical T1 renal mass assessment: Does it have a real benefit?
Asi T; Tuncali MÇ; Tuncel M; Alkanat NEİ; Hazir B; Kösemehmetoğlu K; Baydar DE; Akdoğan B
Urol Oncol; 2020 Dec; 38(12):937.e11-937.e17. PubMed ID: 32859460
[TBL] [Abstract][Full Text] [Related]
17. 99m Tc-MIBI SPECT/CT Evaluation of a Renal Collision Tumor.
Ali AA; Sivathapandi T; Gupta R; Master VA; Marcus C
Clin Nucl Med; 2023 Aug; 48(8):e390-e392. PubMed ID: 37335313
[TBL] [Abstract][Full Text] [Related]
18. Integrated multislice CT and Tc-99m Sestamibi SPECT-CT evaluation of solitary pulmonary nodules.
Sergiacomi G; Schillaci O; Leporace M; Laviani F; Carlani M; Manni C; Danieli R; Simonetti G
Radiol Med; 2006 Mar; 111(2):213-24. PubMed ID: 16671379
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of 99mTc-sestamibi SPECT/CT for detecting renal oncocytomas and other benign renal lesions: a systematic review and meta-analysis.
Wilson MP; Katlariwala P; Murad MH; Abele J; McInnes MDF; Low G
Abdom Radiol (NY); 2020 Aug; 45(8):2532-2541. PubMed ID: 32193593
[TBL] [Abstract][Full Text] [Related]
20.
Campbell SP; Tzortzakakis A; Javadi MS; Karlsson M; Solnes LB; Axelsson R; Allaf ME; Gorin MA; Rowe SP
Br J Radiol; 2018 Apr; 91(1084):20170526. PubMed ID: 29271233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
